Article 1
The expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 set out in Implementing Decision (EU) 2023/460 is postponed to 31 December 2027.
Commission Implementing Decision (EU) 2025/1791 of 10 September 2025 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 set out in Implementing Decision (EU) 2023/460 is postponed to 31 December 2027.
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.